Shanghai Fosun Pharmaceutical Group Co Ltd (2196)

Currency in HKD
21.00
+0.42(+2.04%)
Closed·
2196 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.3021.20
52 wk Range
12.4429.00
Key Statistics
Bid/Ask
20.98 / 21.00
Prev. Close
20.58
Open
20.5
Day's Range
20.3-21.2
52 wk Range
12.44-29
Volume
4.15M
Average Volume (3m)
4.27M
1-Year Change
57.6577%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2196 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.77
Upside
+46.50%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Shanghai Fosun Pharmaceutical Group Co Ltd Company Profile

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services. Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Employees
40557
Market
Hong Kong

Compare 2196 to Peers and Sector

Metrics to compare
2196
Peers
Sector
Relationship
P/E Ratio
21.1x17.9x−0.6x
PEG Ratio
0.37−0.590.00
Price/Book
1.4x2.1x2.6x
Price / LTM Sales
1.8x2.5x3.4x
Upside (Analyst Target)
53.1%21.7%41.8%
Fair Value Upside
Unlock20.0%4.8%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30.77
(+46.50% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Hold27.35+30.24%18.62MaintainOct 31, 2025
Citi
Buy35.30+68.10%25.00MaintainSep 18, 2025
Goldman Sachs
Hold18.62-11.33%16.38MaintainAug 28, 2025
HSBC
Hold17.20-18.10%13.00MaintainJun 10, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.24%
Dividend Yield
1.67%
Industry Median 2.02%
Annualized payout
0.35
Paid annually
5-Years Growth
-3.88%
Growth Streak

Earnings

Latest Release
Oct 28, 2025
EPS / Forecast
0.31 / 0.25
Revenue / Forecast
9.88B / 10.27B
EPS Revisions
Last 90 days

2196 Income Statement

People Also Watch

8.93
0288
+1.59%
24.46
0914
+2.43%
13.580
2600
+2.96%
23.60
1530
-3.12%
124.00
0316
0.00%

FAQ

What Is the Shanghai Fosun Pharmaceutical (2196) Stock Price Today?

The Shanghai Fosun Pharmaceutical stock price today is 21.00

What Stock Exchange Does Shanghai Fosun Pharmaceutical Trade On?

Shanghai Fosun Pharmaceutical is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Shanghai Fosun Pharmaceutical?

The stock symbol for Shanghai Fosun Pharmaceutical is "2196."

Does Shanghai Fosun Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Shanghai Fosun Pharmaceutical dividend yield is 1.67%.

What Is the Shanghai Fosun Pharmaceutical Market Cap?

As of today, Shanghai Fosun Pharmaceutical market cap is 77.62B.

What Is Shanghai Fosun Pharmaceutical's Earnings Per Share (TTM)?

The Shanghai Fosun Pharmaceutical EPS (TTM) is 1.24.

When Is the Next Shanghai Fosun Pharmaceutical Earnings Date?

Shanghai Fosun Pharmaceutical will release its next earnings report on Mar 25, 2026.

From a Technical Analysis Perspective, Is 2196 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Shanghai Fosun Pharmaceutical Stock Split?

Shanghai Fosun Pharmaceutical has split 0 times.

How Many Employees Does Shanghai Fosun Pharmaceutical Have?

Shanghai Fosun Pharmaceutical has 40557 employees.

What is the current trading status of Shanghai Fosun Pharmaceutical (2196)?

As of Jan 27, 2026, Shanghai Fosun Pharmaceutical (2196) is trading at a price of 21.00, with a previous close of 20.58. The stock has fluctuated within a day range of 20.30 to 21.20, while its 52-week range spans from 12.44 to 29.00.

What Is Shanghai Fosun Pharmaceutical (2196) Price Target According to Analysts?

The average 12-month price target for Shanghai Fosun Pharmaceutical is HKD30.77, with a high estimate of HKD36.14186463 and a low estimate of HKD24.68063649. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +46.50% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.